NCT00852631View on ClinicalTrials.gov

Seroquel XR in Adults With Schizophrenia

PHASE3TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Schizophrenia
Interventions
DRUG

Quetiapine fumarate (Seroquel)

600mg Extended release tablet, oral, once daily

Trial Locations (3)

Unknown

Research Site, Bangkok

Research Site, Chiang Mai

Research Site, Songkhla

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY